# Immunotherapy With Adaptive Pulse Radiotherapy in Solid Tumors

> **NCT07381231** · PHASE2 · RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 35 (estimated)

## Conditions studied

- Cancer

## Interventions

- **RADIATION:** Pulse radiation therapy

## Key facts

- **NCT ID:** NCT07381231
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-26
- **Primary completion:** 2028-09-30
- **Final completion:** 2031-09-30
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07381231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07381231, "Immunotherapy With Adaptive Pulse Radiotherapy in Solid Tumors". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT07381231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*